# BSL-1 vs BSL-2: Key Differences [Biosafety level](/knowledge/diagnostics/emerging-tech/biosafety-levels-1-4-a-comparative-framework-for-diagnostic-laboratory-design) 1 (BSL-1) is the containment level for well-characterized agents that do not consistently cause disease in healthy adults and can be handled on an open bench, while biosafety level 2 (BSL-2) adds restricted access, documented annual training, a biosafety cabinet for aerosol-generating steps, and formal decontamination for agents of moderate hazard and for the human and animal specimens that carry them. The rule of thumb for choosing between biosafety level 1 or 2 is short. If the material comes from a human or animal patient, or the agent is known to make people sick, plan for BSL-2. If you are handling a named teaching strain, a bacteriophage, a plasmid-bearing laboratory strain, or a validated non-replicating construct, BSL-1 is usually the right and sufficient answer. This guide compares biosafety level 1 vs 2 on the criteria that decide real choices, explains each level on its own terms, walks through worked scenarios from teaching benches to clinical laboratories, and closes with the mistakes that cause most biosafety problems at the bench. ## What a Biosafety Level Actually Decides A biosafety level is a package of agent restrictions, work practices, safety equipment, facility features, and training requirements that a laboratory applies together. The four levels used in the United States are defined in Biosafety in Microbiological and Biomedical Laboratories (BMBL), the CDC and NIH publication that clinical, research, and teaching laboratories treat as the standard. The starting point for any assignment is the risk group of the agent. Risk group 1 (RG1) organisms are not known to cause disease in healthy adults. Risk group 2 (RG2) organisms cause human disease of variable severity, with moderate individual risk and limited community spread. Risk group 3 (RG3) organisms cause serious disease and may spread through the air. Risk group 4 (RG4) organisms cause severe disease with a real risk of person-to-person spread. Risk group describes the agent. Biosafety level describes the laboratory and the work. A biosafety level usually tracks the risk group, but the assignment weighs three more variables: what you do with the agent, how much of it you handle, and who is doing the work. That is why a biosafety level is not a property of an organism. A nonpathogenic Escherichia coli cloning strain is a BSL-1 organism on an open bench. Concentrating liters of any cultured organism by centrifugation raises exposure risk and can justify added controls even when the agent itself is RG1. The level is assigned in writing by the institution, normally by the biosafety officer or the institutional biosafety committee (IBC), after a documented biosafety risk assessment. A bench scientist proposes the level, the responsible committee confirms it, and the laboratory manual records it. ## BSL-1 in Plain Terms BSL-1 is the baseline. It covers agents that are well characterized and not known to consistently cause disease in immunocompetent adults, meaning people with healthy immune systems. Typical examples are Bacillus subtilis, Escherichia coli K-12 derivatives, Saccharomyces cerevisiae (baker's yeast), and most bacteriophages, which are viruses that infect bacteria. Work happens on an open bench using standard microbiological practices: - Wash hands after handling cultures and before leaving the laboratory. - Keep food, drink, and cosmetics out of the laboratory. - Handle sharps carefully and minimize their use. - Decontaminate work surfaces after use and after any spill. - Decontaminate cultures and contaminated waste before disposal. - Wear a lab coat and safety glasses when splash is possible, and gloves when hand contamination is possible. - Maintain a program for controlling insects and rodents. BSL-1 does not require a biosafety cabinet, restricted access, biohazard signage, special ventilation, or documented annual training. Personnel still need orientation before their first bench session, because at this level the standard practices are the entire containment package. If the practices fail, nothing else stands between the worker and the culture. ### Typical BSL-1 settings Undergraduate teaching laboratories, water and food testing for indicator organisms, molecular cloning, protein expression, phage work, and non-replicating assays. Many institutions also handle well-characterized cell lines with no human origin and no history of contaminating microbes at BSL-1, although a large share of culture work defaults to BSL-2 because of the specimen source or the reagents involved. The call belongs to the institution, not to the person at the bench. ### What BSL-1 does not permit BSL-1 is not a license for anything labeled "harmless-looking." Unknown isolates from clinical or animal sources, organisms with any disease association, large-scale culture, and procedures that concentrate organisms all push the work up a level or demand added controls. Recombinant work carries its own oversight layer as well, and the IBC reviews constructs, not just organisms. ### Real BSL-1 work: validated surrogates A surrogate is a harmless organism used to stand in for a dangerous one while methods are developed and validated. Surrogates let researchers answer questions about a high-hazard pathogen without ever handling it. During the 2014 West African Ebola outbreak, conflicting chlorine-based surface disinfection protocols were circulating, and the evidence behind them was thin. To build that evidence without BSL-4 work at every step, researchers screened four bacteriophages as BSL-1 surrogates for Ebola virus, exposing MS2, M13, Phi6, and PR772 to 0.1 percent and 0.5 percent sodium hypochlorite (NaOCl, the active ingredient in household bleach) on stainless steel for 1, 5, and 10 minutes [1]. MS2 and M13 survived better than Ebola virus, with 3.4 and 3.5 log10 reductions after 10 minutes at 0.5 percent NaOCl, which would have made disinfectants look weaker than they are. PR772 failed in the other direction, losing more than 4.8 log10 after a single minute. Phi6 landed closest to the target, with a 4.1 log10 reduction after 5 minutes and no detectable survivors after 10 minutes, slightly more resistant than Ebola virus itself, and the authors recommended it for chlorine disinfection testing [1]. A log10 reduction is a tenfold drop in viable organisms, so a 4.1 log10 reduction means the count fell by a factor of roughly 12,600. The practical lesson is that BSL-1 organisms can carry the scientific load of experiments that would otherwise demand the highest containment, provided the surrogate is validated against the real pathogen rather than assumed. ### Real BSL-1 work: a drug screen without live virus The same logic applies to drug development. Cellular assays for SARS-CoV-2 antivirals normally require BSL-3 because they use replicating viral particles, which limits how many laboratories can run them. One team rebuilt the question to avoid the virus entirely, expressing the SARS-CoV-2 main protease (Mpro, the viral enzyme that cuts viral proteins) in mammalian cells as a construct tagged with glutathione S-transferase (GST) at one end and hemagglutinin (HA) at the other, then monitoring the enzyme's self-cleavage, called autodigestion [2]. No virus replicates, so the assay runs at BSL-1. In that system, the compounds GC376 and boceprevir inhibited Mpro autodigestion, while carmofur and ebselen did not [2]. The assay is straightforward, inexpensive, and runnable in standard laboratories, which is exactly what a well-designed BSL-1 system should look like. ## BSL-2 in Plain Terms BSL-2 is the working level for agents of moderate hazard, organisms associated with human disease of variable severity for which treatments or preventions often exist. Typical examples are Salmonella enterica, Staphylococcus aureus, influenza virus, and hepatitis B virus or HIV when they appear in diagnostic specimens. BSL-2 is also the default level for clinical material of any kind, because a specimen from a human or animal patient can carry an agent nobody has identified yet. Environmental work is not automatically BSL-1 either. In a survey of fungal communities in constructed wetlands and wastewater stabilization ponds, species with potential pathogenicity for humans and animals accounted for over 45 percent of the fungal species and fell into BSL-1 and BSL-2 groups, with potentially plant-pathogenic species adding another 31.5 percent [3]. A technician enumerating fungi from a treatment plant is handling a mixed population that includes BSL-2 members, and the risk assessment has to reflect that. ### What BSL-2 adds BSL-2 keeps every BSL-1 practice and layers on the following: - Access to the laboratory is limited while work with the agents is in progress. - A biohazard warning sign is posted at the entrance, listing the agents handled, the supervisor's name and contact, and required personal protective equipment (PPE). - Personnel receive documented, lab-specific training, refreshed annually, and the laboratory maintains its own [biosafety manual](/knowledge/diagnostics/emerging-tech/biosafety-manual-development-a-template-for-diagnostic-laboratories). - A biosafety cabinet (BSC), an enclosed workspace whose high-efficiency particulate air (HEPA) filtration protects the worker, the sample, and the room, is required for any manipulation that can create aerosols or splashes. An aerosol is a suspension of droplet nuclei small enough to stay airborne and be inhaled. - Gloves are required, along with a dedicated lab coat and face protection when splash is possible. - Cultures and wastes are decontaminated by a documented method, usually an autoclave (a pressurized steam sterilizer) or a validated chemical disinfectant. - Sharps precautions, spill response, and exposure reporting procedures are written down and rehearsed. - Vacuum lines are protected with filters and traps. - The facility provides a handwashing sink near the exit and an eyewash station. - Medical surveillance is provided as appropriate to the agent, and staff with human blood exposure risk are offered hepatitis B vaccination under the OSHA Bloodborne Pathogens Standard, which also requires treating all human blood and body fluids as infectious, the approach called universal precautions. One facility feature does not change between the two levels: neither BSL-1 nor BSL-2 requires directional airflow or negative pressure. Those engineering controls begin at BSL-3. ### Real BSL-2 work in the literature Four studies show how BSL-2 absorbs questions that sound like they need higher containment. A serological (blood antibody) survey of Middle East respiratory syndrome coronavirus (MERS-CoV) in Ethiopian livestock used a pseudotyped vesicular stomatitis virus, an unrelated viral carrier dressed in the MERS-CoV [spike protein](/blog/guides/spike-protein), for virus neutralization tests, which measure whether antibodies in serum block infection, run entirely in a BSL-2 laboratory. The results matched neutralization tests done with live MERS-CoV, outperformed two ELISA (enzyme-linked immunosorbent assay) formats, and found antibodies only in dromedary camels [4]. The authors concluded that serological testing for MERS-CoV can be conducted in a BSL-2 laboratory. For Rift Valley fever virus, a one-step real-time reverse transcription PCR (rRT-PCR) and an immunohistochemical method, which stains fixed tissue with antibodies to reveal viral antigen, were developed and evaluated specifically for use in BSL-2 diagnostic laboratories [5]. Molecular detection and fixed-tissue staining bring high-consequence agents within reach of ordinary diagnostic laboratories because the infectious material is inactivated or embedded before analysis. An animal model pushed the same idea further. Tuberculosis drug susceptibility testing normally requires BSL-3 because virulent Mycobacterium tuberculosis strains are RG3. A BSL-2-compatible mouse model uses the auxotrophic mc26206 strain, an attenuated strain that cannot synthesize an essential nutrient and therefore cannot survive outside supplemented media, while retaining all of the organism's virulence genes [6]. The model supported infection, drug administration, and bacterial burden measurement for compounds including rifampicin, entirely at BSL-2. BSL-2 equipment also does double duty as a decontamination unit. In an antidoping laboratory handling human urine, 15 minutes of UV-C exposure (short-wave ultraviolet light) inside a BSL-2 cabinet, with samples sealed in their original bottles, was used to destroy DNA and RNA including possible SARS-CoV-2, and none of 444 measured analytes lost stability under those conditions [7]. ## Biosafety Level 1 vs 2: Side-by-Side Comparison | Feature | BSL-1 | BSL-2 | |--|--|--| | Agent hazard profile | Well characterized, not known to consistently cause disease in healthy adults | Moderate hazard, associated with human disease of variable severity | | Typical agents | E. coli K-12, Bacillus subtilis, baker's yeast, bacteriophages such as MS2 and Phi6 | Salmonella enterica, Staphylococcus aureus, influenza virus, hepatitis B virus and HIV in diagnostic specimens | | Sample source | Non-clinical, defined laboratory strains | Human or animal clinical material is the default trigger | | Work surface | Open bench acceptable for all permitted work | Open bench for routine steps, biosafety cabinet for aerosol- or splash-generating steps | | Access control | Not restricted | Limited to trained personnel while agents are in use | | Signage | No biohazard sign required | Biohazard sign with agent name, supervisor contact, and PPE requirements | | Training | Orientation to standard microbiological practices | Documented, lab-specific, annual training plus a laboratory biosafety manual | | PPE | Lab coat, safety glasses as needed, gloves when contamination is possible | Dedicated lab coat, gloves required, face protection when splash is possible | | Facility features | Handwashing sink, door, cleanable surfaces | Same, plus eyewash station, sink near the exit, autoclave or validated decontamination method | | Ventilation | No special requirements | No directional airflow required, that begins at BSL-3 | | Waste handling | Decontaminated before disposal under standard practices | Decontaminated by a documented method, with a sharps program and exposure plan | | Medical surveillance | Not routine | As appropriate to the agent, hepatitis B vaccination offer for human blood exposure | | Typical work | Teaching cultures, cloning, phage disinfection testing, non-replicating assays | Stool and wound cultures, bloodborne pathogen testing, pseudovirus neutralization, molecular detection of high-consequence agents | The difference between biosafety level 1 and 2 is not a ranking of how safe the rooms are. It is a difference in what each room is allowed to hold and what barriers must stand between the worker and the material. Three of those differences change daily behavior more than the rest. First, where the work happens: BSL-1 work lives on the open bench, while BSL-2 work migrates to the biosafety cabinet whenever a procedure can splash or aerosolize. Second, who can be in the room: BSL-2 limits access while agents are in use and posts a sign that says why. Third, what the paperwork requires: BSL-2 demands documented annual training and a lab-specific manual, which turns biosafety from a habit into a verifiable program. ## The Criteria That Decide BSL-1 or BSL-2 ![A short yes or no path that starts with the sample source and ends at a BSL-2 floor for any human or animal clinical material.](/article-images/illustrations/biosafety-level-1-vs-2-bsl-triage.webp) ### Criterion 1: The agent and its risk group The named organism and its risk group set the starting point. Named RG1 organisms with a clean handling history support BSL-1. RG2 organisms, and any organism you cannot identify, support BSL-2. An unknown isolate from a clinical source stays at BSL-2 until identification proves otherwise. ### Criterion 2: Where the sample came from Source trumps the organism in practice. Human blood, serum, urine, swabs, tissue, and human-derived cell lines carry a BSL-2 floor under universal precautions, regardless of the patient's diagnosis. Animal clinical specimens behave the same way in veterinary and diagnostic settings. Environmental samples are judged by what they plausibly contain, which is why wastewater work is treated as a mixed BSL-1 and BSL-2 population [3]. ### Criterion 3: What you do to it Procedures create exposure routes. Pipetting, vortexing, blending, sonication, open-tube centrifugation, and animal handling can all generate aerosols or splashes. Cell sorting deserves special attention because conventional fluorescence-activated cell sorting (FACS) sprays droplets from the nozzle, which is why sorting samples containing RG3 pathogens such as Francisella tularensis, Mycobacterium tuberculosis, Yersinia pestis, or SARS-CoV-2 normally lands in BSL-3. In one validation, a fully closed, cartridge-based sorter produced no aerosols during the sort and could be used on the benchtop even in a BSL-3 setting, with the institutional biosafety committee performing its own in-house risk assessment [8]. The lesson generalizes: equipment belongs in the risk assessment item by item, and a closed design can change the level a procedure demands. ### Criterion 4: Scale and concentration Small volumes of dilute culture behave differently from liters of concentrated organism. Preparative centrifugation, large-scale fermentation, and purified lots raise the consequences of a spill or a rotor failure, and the risk assessment should add controls as scale grows. ### Criterion 5: The people in the room Training, competency, health status, and vaccination change the risk picture. Immunocompromised personnel, pregnancy, and absent immunity to a vaccine-preventable agent all belong in the assessment. At BSL-2, medical surveillance and the hepatitis B vaccination offer exist precisely because the people are part of the containment equation. ### Criterion 6: What happens if containment fails Severity weighs the decision. An exposure to an RG1 organism is usually a nuisance. An exposure to Salmonella or to hepatitis B contaminated blood is a medical event, and the availability of treatment, post-exposure prophylaxis, or vaccination shapes how much barrier the work deserves. ## Worked Scenarios: BSL-1 or BSL-2? **Scenario 1: An undergraduate teaching lab streaks environmental isolates on nutrient agar.** BSL-1, provided the isolates come from RG1 sources and the institution has assigned the activity in writing. If the same class cultures swabs from human skin or a clinic, the exercise moves to BSL-2 practices, because the source is clinical. **Scenario 2: A research group tests chlorine disinfection with bacteriophages.** BSL-1. Phages are RG1, the work is bench scale, and a validated surrogate such as Phi6 can carry conclusions about far more dangerous viruses [1]. **Scenario 3: A laboratory screens Mpro inhibitors with a tagged, non-replicating construct.** BSL-1. The construct cannot produce virus, the cells are standard lines, and the assay was designed for standard laboratories [2]. **Scenario 4: A [veterinary diagnostic lab](/blog/careers/veterinary-diagnostic-laboratory-careers-from-bench-to-leadership) cultures feces from a dog with bloody diarrhea to look for Salmonella and Campylobacter.** BSL-2. The sample is animal clinical material with explicit suspicion of intestinal RG2 pathogens, so BSL-2 practices, PPE, and a biosafety cabinet for enrichment and plating steps are the floor. **Scenario 5: A team runs MERS-CoV neutralization assays on camel sera using a pseudotyped virus.** BSL-2. The pseudovirus removes replicating MERS-CoV from the equation, and the assay was validated in BSL-2 against live-virus results [4]. **Scenario 6: A diagnostic laboratory detects Rift Valley fever virus RNA from field samples.** BSL-2, using the rRT-PCR method validated for BSL-2 diagnostic laboratories, with inactivation validated as part of the workflow [5]. **Scenario 7: A technician enumerates fungi from a wastewater treatment plant.** The risk assessment should treat the work as BSL-2, because the population includes species with human and animal pathogenicity in the BSL-2 group, even though many members are harmless [3]. **Scenario 8: A core facility sorts human cells infected with an RG2 virus.** The default is BSL-2 with the sort performed in a certified biosafety cabinet or a closed, aerosol-free system, and the IBC decides after reviewing the instrument and the agent together [8]. ## When to Use Biosafety Level 1 Use BSL-1 when all of the following hold: 1. The agent is named and classified as RG1 by the institution. 2. The material has no human or animal clinical origin. 3. No procedure concentrates the organism or generates heavy aerosols. 4. Staff health conditions have been considered, and none change the risk picture. 5. The assignment is written into the laboratory's biosafety documentation. BSL-1 is not a downgrade taken to avoid paperwork. It is the correct level for genuinely low-hazard work, and it protects scarce containment capacity. Overassigning BSL-2 to RG1 teaching work ties up biosafety cabinets and teaches students that biosafety is a costume rather than a chain of reasoning. Underassigning it creates exposures. The level should match the risk assessment in both directions. ## When BSL-2 Is the Floor Treat BSL-2 as the minimum when any of the following applies: - Any human-derived material, including blood, serum, urine, swabs, tissue, and human cell lines. - Any animal clinical specimen. - Any RG2 organism, in any quantity. - Any culture set up to recover pathogens from a patient or from an environmental source of unknown composition. - Any aerosol-generating manipulation of RG2 material. - Any recombinant system expressing pathogen virulence factors in mammalian cells, unless the IBC approves a lower level on the basis of validation. ## Beyond BSL-2: BSL-2+, BSL-3, and BSL-4 ### BSL-2+ (enhanced BSL-2) BSL-2+ is not one of the four formal levels. It is the practical name for a laboratory that meets BSL-2 and adds selected BSL-3 features, such as dedicated ventilation, access controls, or sealed penetrations, because the agents, quantities, or procedures justify more engineering without meeting full BSL-3 criteria. A validated pilot-scale enhanced BSL-2 containment facility was built specifically to evaluate produce disinfection technologies safely, an example of engineering matched to a defined experimental need [9]. Ventilation design matters at this tier. In a study of a typical enhanced BSL-2 laboratory, researchers tracked the spatial distribution of bioaerosols, airborne particles of biological origin, and compared four ventilation strategies. Cross-supply with downward return (CD) performed best, with a contaminant removal index of 1.48, a measure of how effectively the airflow sweeps contamination out of the room, and an air change efficiency of 0.603, a measure of how quickly supplied air replaces room air. Upward supply with upward return (UU) followed at 0.595. Lateral supply with downward return risked airflow short-circuiting, in which supply air bypasses the occupied work zone, and upward supply with downward return gave balanced protection. Benches and equipment themselves disturbed the airflow, which is a useful reminder that room layout is part of containment [10]. ### BSL-3 BSL-3 applies to RG3 agents, which cause serious disease and often transmit through the air, such as Mycobacterium tuberculosis, Francisella tularensis, and Yersinia pestis. It adds directional airflow, negative pressure relative to surrounding spaces, sealed rooms, and dedicated systems. International guidance for BSL-3 work, and for gain-of-function experiments that increase an agent's capabilities, diverges between countries, so teams working across borders must reconcile the applicable rules before starting [11]. ### BSL-4 BSL-4 is reserved for RG4 agents such as Ebola virus, where infection is severe and person-to-person spread is a real risk. The positive pressure suit is the signature of BSL-4, delivering HEPA-filtered air through an umbilical line and holding the suit interior at positive pressure, so a breach pushes air outward instead of drawing contaminated air in. In an evaluation of nine suits from five manufacturers, carbon dioxide inside the suits stayed below 1 percent during normal activity [12]. The distance between BSL-2 practice and a suit laboratory explains why so much modern work goes into moving experiments down the hierarchy instead of up. ### Moving work down the hierarchy ![Side by side comparison of a validated BSL-1 surrogate and a BSL-2 pseudovirus system, covering what each is, what it answers and its limit.](/article-images/illustrations/biosafety-level-1-vs-2-surrogate-vs-pseudovirus.webp) Virus-like particles (VLPs), empty viral shells that cannot replicate, and pseudoviruses, unrelated viral carriers dressed in a pathogen's surface protein, let laboratories study entry, neutralization, and drug response without the live agent. An Ebola VLP reporter system enabled antiviral evaluation under non-BSL-4 conditions [13]. The BSL-1 protease assay [2], the BSL-2 pseudovirus neutralization test [4], and the BSL-2 tuberculosis mouse model [6] all follow the same pattern. Redesign the experiment, and the containment requirement falls. ## How to Run a Biosafety Risk Assessment A biosafety risk assessment is the documented process of identifying hazards, evaluating exposure routes, and selecting controls before work begins. It is also the document that justifies the assigned level, so a specific, written assessment is the difference between a defensible decision and a habit. 1. **Identify the agent and the matrix.** Name the organism, its risk group, and everything else in the sample, including host cells, blood, and preservatives. 2. **List every procedure.** Pipetting, vortexing, centrifugation, sonication, sorting, animal handling, each with its exposure routes. 3. **Evaluate the people.** Training, competency, health status, vaccination, and the consequences of an exposure for each individual. 4. **Select controls in order.** Eliminate or substitute the hazard first, then engineering controls such as a biosafety cabinet or a closed sorting cartridge, then administrative controls such as training, signage, and access limits, then PPE. 5. **Assign the level in writing.** The biosafety officer or IBC signs off, and the lab manual states the level, the agents, and the required practices. 6. **Reassess on change.** A new agent, new equipment, new personnel, or an incident reopens the assessment. Policy analysis supports this structure. A review of 137 central-level laboratory biosafety policies in China found that their content clusters into three areas, management systems, facility and equipment and containment barriers, and operational technical standards, and that policy quality varied across documents [14]. The three-area frame works as a checklist for any program, and the variability is a reminder that a written policy contains nothing until it is implemented and verified at the bench. ## Microbiology Biosafety Training at Each Level At BSL-1, the requirement is orientation to standard microbiological practices before the first bench session, covering handwashing, food and drink restrictions, sharps handling, surface decontamination, waste segregation, and spill cleanup. The training can be brief because the practices are the containment. At BSL-2, training becomes a documented program. The laboratory maintains a lab-specific biosafety manual, personnel receive training on the specific agents and procedures they will handle, and refreshers run annually or whenever procedures change. Hands-on instruction in biosafety cabinet use, centrifuge safety, spill response, and exposure reporting matters more than a signature on a slide deck, because BSL-2 incidents trace back to technique far more often than to equipment failure. Biosafety cabinets are certified on installation and recertified annually, and staff should know what a failed certification means for their work. New personnel operate under direct supervision until their competency is documented, and visitors or maintenance staff who might enter while agents are in use need the same access discipline the sign on the door promises. ## Common Mistakes and Limitations **Treating the level as a property of the organism.** The same agent can sit at different levels depending on procedure, scale, and staff. The risk assessment, not the species name, sets the level. **Assuming BSL-1 means no rules.** Standard microbiological practices, decontamination, and waste handling still apply at BSL-1. The practices are the entire containment package at that level, so skipping them removes everything. **Running human specimens on the open bench at BSL-1 because the volume is small.** Human clinical material carries a BSL-2 floor regardless of volume, because any specimen can carry an agent the submitter does not know about. **Buying a biosafety cabinet and calling the room BSL-2.** A cabinet that is uncertified, badly placed, or used as a storage surface adds no protection, and a biosafety cabinet is not a fume hood, so it does not protect against chemical vapor. BSL-2 status rests on practices, training, signage, access control, and decontamination as much as on equipment. **Choosing a BSL-1 surrogate without validation.** Surrogate choice changed the conclusion in the Ebola disinfection work, where two phage candidates were more chlorine resistant than the target virus and one was too fragile, leaving only the validated surrogate able to support recommendations [1]. **Assuming a molecular method makes a sample safe.** Extraction and lysis can aerosolize material before inactivation is complete, which is why detection methods are validated for the containment level before routine diagnostic use [5]. **Ignoring aerosol-generating equipment.** Conventional cell sorters spray droplets, sonicators and blenders release aerosols, and a centrifuge failure can aerosolize an entire rotor. Equipment belongs in the risk assessment item by item, and closed designs can change the answer [8]. **Limitation.** Biosafety level assignments are institutional decisions that depend on the specific agents, procedures, facility, and staff of a given laboratory. Individual determinations belong with the laboratory's biosafety officer or institutional biosafety committee, not with a general guide. ## Frequently Asked Questions ### Can human samples be handled at BSL-1? No. Human clinical material, including blood, urine, swabs, and tissue, is handled at BSL-2 as the minimum, because any specimen can carry bloodborne or other agents regardless of the patient's diagnosis, and US occupational rules treat human material as potentially infectious. ### Is BSL-2 safer than BSL-1? Neither level is safer as a room. They are matched packages, and safety comes from matching the level to the risk assessment and then executing it. A well-run BSL-1 laboratory with RG1 agents is safe, and a BSL-2 laboratory exists because some agents and specimens need more barriers. ### What organisms are handled at BSL-1 versus BSL-2? BSL-1 covers organisms such as E. coli K-12, Bacillus subtilis, baker's yeast, and bacteriophages. BSL-2 covers Salmonella, Staphylococcus aureus, influenza virus, hepatitis B virus and HIV in diagnostic specimens, and most human cell culture. ### Does BSL-2 require a biosafety cabinet for every procedure? No. Routine manipulations with low splash risk can be done on the open bench with the required PPE. A biosafety cabinet is required for procedures that create aerosols or droplets, such as vortexing, open-tube centrifugation, blending, and vigorous pipetting. ### Can a BSL-2 lab work with high-consequence viruses? Sometimes. Diagnostic specimens, pseudoviruses, virus-like particles, and non-replicating constructs can often be handled at BSL-2 or below with validation, while propagating replication-competent high-consequence virus requires BSL-3 or BSL-4 containment. ### Do BSL-1 labs need annual documented training like BSL-2 labs? No. The documented annual requirement is a BSL-2 feature. BSL-1 workers still need orientation to standard microbiological practices before starting bench work, and periodic refreshers are good practice. ## Sources 1. [Selection of a Biosafety Level 1 (BSL-1) surrogate to evaluate surface disinfection efficacy in Ebola outbreaks: Comparison of four bacteriophages](https://pubmed.ncbi.nlm.nih.gov/28531182/) 2. [Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine](https://pubmed.ncbi.nlm.nih.gov/38891954/) 3. [Evaluation of the Richness, Species Diversity, and Biosafety of Saprotrophic Fungal Communities in Constructed Wetlands and Biological Wastewater Ponds](https://doi.org/10.3390/w15010031) 4. [Evaluation of serological assays available in a biosafety level 2 laboratory and their application for survey of Middle East respiratory syndrome coronavirus among livestock in Ethiopia](https://pubmed.ncbi.nlm.nih.gov/31685722/) 5. [Development and evaluation of one-step rRT-PCR and immunohistochemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories.](https://pubmed.ncbi.nlm.nih.gov/22172972/) 6. [An in vivo biosafety-level-2-compatible model of Mycobacterium tuberculosis infection for drug susceptibility testing](https://pubmed.ncbi.nlm.nih.gov/35880128/) 7. [Biosafety Level 2 Cabinet UV-C Light Exposure of Sports Antidoping Human Urine Samples does Not Affect the Stability of Selected Prohibited Substances.](https://pubmed.ncbi.nlm.nih.gov/33119942/) 8. [Validation and Application of a Benchtop Cell Sorter in a Biosafety Level 3 Containment Setting](https://pubmed.ncbi.nlm.nih.gov/36034097/) 9. [Development and Validation of a Pilot Scale Enhanced Biosafety Level Two Containment for Performance Evaluation of Produce Disinfection Technologies](https://doi.org/10.1177/153567600801300106) 10. [Spatial distribution of bioaerosols and evaluation of four ventilation method on controlling their diffusion in a typical enhanced biosafety level 2 laboratory.](https://pubmed.ncbi.nlm.nih.gov/38889462/) 11. [Comparison of International Guidance for Biosafety Regarding Work Conducted at Biosafety Level 3 (BSL-3) and Gain-of-Function (GOF) Experiments](https://pubmed.ncbi.nlm.nih.gov/36090805/) 12. [Evaluation of Nine Positive Pressure Suits for Use in the Biosafety Level-4 Laboratory](https://doi.org/10.1177/1535676018793151) 13. [An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions](https://pubmed.ncbi.nlm.nih.gov/27440895/) 14. [Mining and quantitative evaluation of the laboratory biosafety policy in China.](https://pubmed.ncbi.nlm.nih.gov/40794760/)